PCVX logo

Vaxcyte, Inc. (PCVX) EBIT

annual EBIT:

-$463.93M-$61.66M(-15.33%)
December 31, 2024

Summary

  • As of today (September 14, 2025), PCVX annual earnings before interest & taxes is -$463.93 million, with the most recent change of -$61.66 million (-15.33%) on December 31, 2024.
  • During the last 3 years, PCVX annual EBIT has fallen by -$363.86 million (-363.60%).
  • PCVX annual EBIT is now -1477.45% below its all-time high of -$29.41 million, reached on December 31, 2018.

Performance

PCVX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

quarterly EBIT:

-$226.22M-$45.43M(-25.13%)
June 30, 2025

Summary

  • As of today (September 14, 2025), PCVX quarterly earnings before interest & taxes is -$226.22 million, with the most recent change of -$45.43 million (-25.13%) on June 30, 2025.
  • Over the past year, PCVX quarterly EBIT has dropped by -$73.24 million (-47.87%).
  • PCVX quarterly EBIT is now -2023.32% below its all-time high of -$10.65 million, reached on June 30, 2019.

Performance

PCVX quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

TTM EBIT:

-$604.01M-$73.24M(-13.80%)
June 30, 2025

Summary

  • As of today (September 14, 2025), PCVX TTM earnings before interest & taxes is -$604.01 million, with the most recent change of -$73.24 million (-13.80%) on June 30, 2025.
  • Over the past year, PCVX TTM EBIT has dropped by -$89.51 million (-17.40%).
  • PCVX TTM EBIT is now -4322.36% below its all-time high of -$13.66 million, reached on March 31, 2019.

Performance

PCVX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

PCVX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-15.3%-47.9%-17.4%
3 y3 years-363.6%-366.1%-323.1%
5 y5 years-823.5%-1013.3%-723.1%

PCVX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-363.6%at low-366.1%at low-323.1%at low
5 y5-year-823.5%at low-1013.3%at low-723.1%at low
alltimeall time-1477.5%at low-2023.3%at low-4322.4%at low

PCVX EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$226.22M(+25.1%)
-$604.01M(+13.8%)
Mar 2025
-
-$180.79M(+215.2%)
-$530.77M(+14.3%)
Dec 2024
-$463.93M(+15.3%)
-$57.36M(-58.9%)
-$464.45M(-14.4%)
Sep 2024
-
-$139.63M(-8.7%)
-$542.75M(+5.5%)
Jun 2024
-
-$152.98M(+33.6%)
-$514.50M(+15.3%)
Mar 2024
-
-$114.47M(-15.6%)
-$446.20M(+10.9%)
Dec 2023
-$402.27M(+80.0%)
-$135.66M(+21.8%)
-$402.27M(+16.7%)
Sep 2023
-
-$111.39M(+31.5%)
-$344.66M(+18.4%)
Jun 2023
-
-$84.68M(+20.1%)
-$291.19M(+14.2%)
Mar 2023
-
-$70.54M(-9.6%)
-$255.03M(+14.1%)
Dec 2022
-$223.48M
-$78.05M(+34.8%)
-$223.56M(+28.4%)
Sep 2022
-
-$57.92M(+19.3%)
-$174.07M(+21.9%)
Jun 2022
-
-$48.53M(+24.2%)
-$142.77M(+21.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$39.06M(+36.8%)
-$117.91M(+15.6%)
Dec 2021
-$100.07M(+12.2%)
-$28.56M(+7.3%)
-$101.99M(+8.3%)
Sep 2021
-
-$26.61M(+12.4%)
-$94.17M(+6.3%)
Jun 2021
-
-$23.67M(+2.3%)
-$88.57M(+3.9%)
Mar 2021
-
-$23.14M(+11.6%)
-$85.22M(-4.5%)
Dec 2020
-$89.21M(+77.6%)
-$20.74M(-1.3%)
-$89.21M(+7.4%)
Sep 2020
-
-$21.02M(+3.4%)
-$83.09M(+13.2%)
Jun 2020
-
-$20.32M(-25.1%)
-$73.38M(+15.2%)
Mar 2020
-
-$27.14M(+85.7%)
-$63.71M(+26.8%)
Dec 2019
-$50.23M(+70.8%)
-$14.61M(+29.2%)
-$50.23M(+41.0%)
Sep 2019
-
-$11.31M(+6.1%)
-$35.62M(+46.5%)
Jun 2019
-
-$10.65M(-22.0%)
-$24.31M(+78.0%)
Mar 2019
-
-$13.66M
-$13.66M
Dec 2018
-$29.41M
-
-

FAQ

  • What is Vaxcyte, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual EBIT year-on-year change?
  • What is Vaxcyte, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly EBIT year-on-year change?
  • What is Vaxcyte, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM EBIT year-on-year change?

What is Vaxcyte, Inc. annual earnings before interest & taxes?

The current annual EBIT of PCVX is -$463.93M

What is the all time high annual EBIT for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual earnings before interest & taxes is -$29.41M

What is Vaxcyte, Inc. annual EBIT year-on-year change?

Over the past year, PCVX annual earnings before interest & taxes has changed by -$61.66M (-15.33%)

What is Vaxcyte, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of PCVX is -$226.22M

What is the all time high quarterly EBIT for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly earnings before interest & taxes is -$10.65M

What is Vaxcyte, Inc. quarterly EBIT year-on-year change?

Over the past year, PCVX quarterly earnings before interest & taxes has changed by -$73.24M (-47.87%)

What is Vaxcyte, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of PCVX is -$604.01M

What is the all time high TTM EBIT for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM earnings before interest & taxes is -$13.66M

What is Vaxcyte, Inc. TTM EBIT year-on-year change?

Over the past year, PCVX TTM earnings before interest & taxes has changed by -$89.51M (-17.40%)
On this page